申请人:Bayer Aktiengesellschaft
公开号:US05712296A1
公开(公告)日:1998-01-27
Substituted pyridines and 2-oxo-1,2-dihydropyridines are prepared by reaction of correspondingly substituted halogenobenzenes with tetrazolylboronic acids. The substituted pyridines and 2-oxo-1,2-dihydropyridines according to the invention can be employed as active compounds in medicaments, in particular for the treatment of arterial hypertension and atherosclerosis.
通过将相应取代的卤代苯与四唑基硼酸反应,可以制备取代的吡啶和2-氧代-1,2-二氢吡啶。根据本发明,这些取代的吡啶和2-氧代-1,2-二氢吡啶可以作为活性化合物应用于药物中,特别是用于治疗动脉高血压和动脉硬化。